Welcome to Multibagg AI
Log in to access personalized features
Discovery themes featuring this stockGet instant AI-powered insights about company performance, financials, and strategy. Ask questions about trends, competition, and developments while receiving responses backed by official documents and market data, with clear attribution to source documents.
Portfolio
Alerts
Ask Iris
Discovery
Timeline
Multibagg AI is an AI powered stock research and analysis platform. We provide data, information, content, and analytics for publicly traded Indian companies listed on NSE and BSE. AI can make mistakes, check important information.
Prices might be delayed by a few minutes.
Join our Exclusive Community
Join our Exclusive Community
Made with 💙 in India. © Finsky Technologies Pvt Ltd. 2026
Discover detailed, AI-driven financial summaries that break down key metrics, trends, and insights—empowering you to make smarter investment decisions.
Gayatri BioOrganics Ltd (GAYATRIBI) is currently trading at 6.90 per share. Stock prices fluctuate during market hours on NSE and BSE based on demand, company updates, and overall market conditions. Refer to the live price chart above for the most recent price movement.
Gayatri BioOrganics Limited is primarily in the business of manufacturing starch and its derivatives, including sorbitol, with facilities in Karnataka and Telangana. The company has one of the largest starch and starch derivative manufacturing units in South India bolstered by a wide distribution network across the country. It leverages a technical collaboration with Lurgi Oil Gas Chemie, Germany for cutting-edge low-pressure hydrogenation technology in sorbitol production. Currently, the company faces financial challenges, including being referred to the Board for Industrial and Financial Reconstruction (BIFR) as its net worth has been fully eroded. The company has initiated backward integration with a starch project to support its sorbitol production, aiming for cost reductions and quality improvements.
Over the past 52 weeks, Gayatri BioOrganics Ltd has traded between a low of ₹6.25 and a high of ₹20.25. The 52-week high and low indicate the stock’s price range over the last year and help investors understand its volatility and recent trading levels.
Gayatri BioOrganics Ltd has a market capitalization of approximately 54.36. Market capitalization represents the total value of a company’s outstanding shares and helps investors understand its size, stability, and relative risk compared to other listed companies.
Gayatri BioOrganics Ltd’s investment profile depends on its business fundamentals, valuation, and long-term outlook. The stock currently trades at a PE ratio of -48.97 and operates in the its sector sector. Investors typically assess financial performance, growth prospects, and individual risk tolerance before making investment decisions.
Based on its market capitalization of 54.36 Cr, Gayatri BioOrganics Ltd is classified as a Small Cap stock. Large-cap stocks are generally more stable, while mid-cap and small-cap stocks tend to offer higher growth potential along with higher price volatility.
Gayatri BioOrganics Ltd operates in the its sector sector. Sector classification matters because companies in the same sector are often affected by similar economic conditions, regulatory changes, and competitive dynamics, which can influence overall stock performance.
The Price-to-Earnings (PE) ratio of Gayatri BioOrganics Ltd is -48.97. The PE ratio compares a company’s share price to its earnings and is commonly used to assess valuation. Comparing the PE ratio with sector peers and historical levels provides better context.
Bearish
6
Neutral
6
Bullish
2
Bearish
36
Neutral
6
Bullish
4
Bearish
30
Neutral
0
Bullish
2
Gayatri BioOrganics Limited is primarily in the business of manufacturing starch and its derivatives, including sorbitol, with facilities in Karnataka and Telangana.
The company has one of the largest starch and starch derivative manufacturing units in South India bolstered by a wide distribution network across the country.
It leverages a technical collaboration with Lurgi Oil Gas Chemie, Germany for cutting-edge low-pressure hydrogenation technology in sorbitol production.
Currently, the company faces financial challenges, including being referred to the Board for Industrial and Financial Reconstruction (BIFR) as its net worth has been fully eroded.
The company has initiated backward integration with a starch project to support its sorbitol production, aiming for cost reductions and quality improvements.
Chemicals & Petrochemicals
Commodity Chemicals
54 Cr
Low Risk
-49.0
42.5
—
—
20.25
6.25
Sales CAGR
Profit CAGR
ROE
ROCE
Board Meeting
Gayatri BioOrganics Ltd. will hold a Board meeting on 2026-08-04 to consider and approve unaudited financial results for quarter ended 30.06.2026; trading window closed from 2026-07-01 till 48 hours after results.
Board Meeting
Gayatri BioOrganics Ltd: Board meeting on 04-08-2026 to consider and approve unaudited financial results and limited review for quarter ended 30.06.2026; trading window closed from 01.07.2026 until 48 hours after results.
| Symbol | Watchlist | Price | Market Cap | P/E | P/B | Div Yield (%) | ROE (%) | ROCE (%) | ROA (%) |
78.49 | 71 Cr | 14.15 | 2.46 | 0.00 | 12.27 | 15.17 | 10.52 | ||
131.00 | 58 Cr | -176.18 | 0.00 | 0.00 | -3.13 | 6.40 | -29.20 | ||
6.90 | 54 Cr | -48.97 | 0.00 | 0.00 | 3.00 | -119.55 | -64.53 | ||
6.27 | 44 Cr | -35.54 | 3.99 | 0.00 | -8.33 | -5.51 | -5.01 | ||
51.78 | 43 Cr | 12.85 | 1.31 | 0.00 | 10.20 | 8.66 | 2.55 | ||
45.00 | 34 Cr | -5.79 | 1.36 | 0.00 | -23.53 | -8.66 | -7.26 | ||
41.43 | 32 Cr | -1599.50 | 0.87 | 0.00 | 2.84 | 3.00 | -0.52 | ||
| Median: 7 Co. | — | 45.00 | 44 Cr | -35.54 | 1.31 | 0.00 | 2.84 | 3.00 | -5.01 |
